当前位置:首页 - 行情中心 - 凯普生物(300639) - 财务分析 - 现金流量表

凯普生物

(300639)

  

流通市值:39.70亿  总市值:40.41亿
流通股本:6.35亿   总股本:6.47亿

现金流量表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,329,673,717.24948,949,382.1620,541,847.133,854,981,645.39
收到的税费返还12,658,612.236,332,248.955,987,636.26908,118.37
收到其他与经营活动有关的现金28,762,221.2817,751,001.777,404,604.0923,288,701.71
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,371,094,550.75973,032,632.82633,934,087.483,879,178,465.47
购买商品、接受劳务支付的现金405,491,127.49310,621,782.55161,373,802.161,088,897,335.61
支付给职工以及为职工支付的现金379,709,509.12285,093,061.89186,832,155.51647,067,649.64
支付的各项税费147,519,198.19132,162,382.9287,657,064.5312,129,105.63
支付其他与经营活动有关的现金248,222,919.35173,069,350.54128,892,985.28521,868,311.29
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,180,942,754.15900,946,577.9564,756,007.452,569,962,402.17
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额190,151,796.672,086,054.9269,178,080.031,309,216,063.3
二、投资活动产生的现金流量:
收回投资收到的现金854,919,990.76728,497,139.34202,150,0002,657,758,096.03
取得投资收益收到的现金-0534,495.1-
处置固定资产、无形资产和其他长期资产收回的现金净额67,247.4256,039.8237,46813,724,953.34
投资活动现金流入的平衡项目0000
投资活动现金流入小计854,987,238.18728,553,179.16202,721,963.12,671,483,049.37
购建固定资产、无形资产和其他长期资产支付的现金325,554,524.75252,329,458.3151,218,230.16734,366,058.73
投资支付的现金735,200,000596,950,000194,200,0002,541,863,699
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,060,754,524.75849,279,458.3345,418,230.163,276,229,757.73
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-205,767,286.57-120,726,279.14-142,696,267.06-604,746,708.36
三、筹资活动产生的现金流量:
吸收投资收到的现金---10,000,000
取得借款收到的现金71,617,50061,617,5001,617,500200,788,722.13
筹资活动现金流入平衡项目0000
筹资活动现金流入小计71,617,50061,617,5001,617,500210,788,722.13
偿还债务支付的现金83,681,072.3250,000,000-253,733,199.6
分配股利、利润或偿付利息支付的现金154,358,101.01153,518,731.73765,887.68114,286,516.94
支付其他与筹资活动有关的现金56,102,296.3254,769,605.815,920,114.7662,178,351.58
筹资活动现金流出平衡项目0000
筹资活动现金流出小计294,141,469.65258,288,337.546,686,002.44430,198,068.12
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-222,523,969.65-196,670,837.54-5,068,502.44-219,409,345.99
四、汇率变动对现金及现金等价物的影响1,818,231.27-3,718,258.88-13,738,364.2713,403,489.9
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-236,321,228.35-249,029,320.64-92,325,053.74498,463,498.85
加:期初现金及现金等价物余额1,024,775,861.21,024,775,861.21,024,775,861.2521,972,638.93
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额788,454,632.85775,746,540.56932,450,807.461,020,436,137.78
补充资料:
净利润-89,357,944.73-1,801,401,742.42
资产减值准备--9,271,266.9-359,241,906
固定资产和投资性房地产折旧-65,015,075.05-155,719,609.26
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-65,015,075.05-155,719,609.26
无形资产摊销-4,816,602.29-11,566,262.54
长期待摊费用摊销-18,492,980.9-14,195,022.1
处置固定资产、无形资产和其他长期资产的损失--6,804,852.35--4,337,070.16
固定资产报废损失-218,019.16-24,446,891.65
公允价值变动损失-5,394.06--42,656.86
财务费用-15,047,162.87-8,183,189.6
投资损失--4,461,060.92--21,308,354.72
递延所得税-11,176,113.3--79,612,962.41
其中:递延所得税资产减少-14,531,415.86--140,996,899.38
递延所得税负债增加--3,355,302.56-61,383,936.97
存货的减少-19,529,714.35--63,360,297.51
经营性应收项目的减少-341,753,870.24--1,919,957,764.68
经营性应付项目的增加--474,707,389.83-698,967,054.03
其他--4,379,114.9-61,475,414.94
现金的期末余额-775,746,540.56-1,020,436,137.78
减:现金的期初余额-1,024,775,861.2-521,972,638.93
公告日期2023-10-262023-08-312023-04-252023-04-15
审计意见(境内)标准无保留意见
TOP↑